MRI in prostate cancer diagnosis: do we need to add standard sampling? A review of the last 5 years.
Armando StabileFrancesco GigantiMark EmbertonCaroline M MoorePublished in: Prostate cancer and prostatic diseases (2018)
MRI-targeted biopsy is more efficient than standard biopsy in detecting clinically significant disease in men with a positive MRI, and results in less detection of clinically insignificant cancer. In men with a negative MRI, a significant minority of men will have clinically significant cancer detected on systematic biopsy.